150 related articles for article (PubMed ID: 369586)
41. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
42. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer.
Koide Y; Wakazono K; Yamagata K; Miyaji M; Yamamoto M
Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433
[TBL] [Abstract][Full Text] [Related]
43. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
Tanaka F; Sawada K; Yonemoto RH
Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
[TBL] [Abstract][Full Text] [Related]
44. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
Tank B; Marquet RL; Vennemans E; Westbroek DL
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
[TBL] [Abstract][Full Text] [Related]
45. Leucocyte adherence inhibition assay (LAI) in cancer of the oral cavity.
Prabha B; Kumary ; Vasudevan DM
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):891-7. PubMed ID: 6540190
[TBL] [Abstract][Full Text] [Related]
46. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
47. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
Thomson DM; Halliday WJ; Phelan K
J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
[TBL] [Abstract][Full Text] [Related]
48. [Hypotheses on the tumoral nature of fibrocystic mastopathy. Review of bibliographic data and experimental immunologic tests].
Cavallini G
Minerva Med; 1982 Sep; 73(34):2147-55. PubMed ID: 7110597
[TBL] [Abstract][Full Text] [Related]
49. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
Meduri F; Doni MG; Merenda R; Bizzarini M; Neri D; Gerunda GE; Maffei Faccioli A
Cancer; 1989 Sep; 64(5):1103-6. PubMed ID: 2667748
[TBL] [Abstract][Full Text] [Related]
50. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
Plain MJ; Whitehead RH; Jose DG
Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
[TBL] [Abstract][Full Text] [Related]
51. Isolation of human tumour-specific antigens associated with beta2 microglobulin.
Thomson DM; Rauch JE; Weatherhead JC; Friedlander P; O'Connor R; Grosser N; Shuster J; Gold P
Br J Cancer; 1978 May; 37(5):753-75. PubMed ID: 77673
[TBL] [Abstract][Full Text] [Related]
52. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
Shenouda G; Thomson DM
Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
[TBL] [Abstract][Full Text] [Related]
53. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
Cavallini G; Berti G; Tioli P
Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321
[TBL] [Abstract][Full Text] [Related]
54. Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.
Gubersky M; Thomson DM; Lajzerowicz M
Cancer Immunol Immunother; 1986; 21(2):107-13. PubMed ID: 3633212
[TBL] [Abstract][Full Text] [Related]
55. Leukocyte adherence inhibition test in lung cancer immunodiagnostic detection.
Lodi M; Cavallini G; Pampolini M
Ital J Surg Sci; 1988; 18(1):25-34. PubMed ID: 2836338
[TBL] [Abstract][Full Text] [Related]
56. Immunologic characteristics of the leukocyte adherence inhibition assay in rheumatoid arthritis.
Tannenbaum H; Wild J
Clin Invest Med; 1983; 6(3):153-9. PubMed ID: 6360455
[TBL] [Abstract][Full Text] [Related]
57. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
58. Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein.
Gouda Z; Thomson DM
Jpn J Cancer Res; 1988 Apr; 79(4):529-37. PubMed ID: 2454907
[TBL] [Abstract][Full Text] [Related]
59. Application of tube LAI assay in larynx cancer patients.
Hasek M; Holán V; Síbl O; Kousalová M
Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
[TBL] [Abstract][Full Text] [Related]
60. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
